MedEnrich | Página principal
Continue Watching
últimos vidéos
últimos vidéos
Brightcove Home Latest Listing
Cáncer de mama
Cáncer de mama
Brightcove Cards Listing
Cáncer de próstata
Brightcove Cards Listing
Mieloma múltiple
Mieloma múltiple
Brightcove Cards Listing
Popular en MedEnrich
Popular in Sin nombre
Mieloma múltiple9m 20s
Integrating Pomalidomide Based Regimens in Multiple Myeloma
Integrating pomalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (RRMM) involves using them as a core regimen, often combined with other agents like bortezomib or monoclonal antibodies for enhanced efficacy.
pomalidomide-dexamethasone
rrmm management
progression-free survival
combination therapies
1
Integrating Pomalidomide Based Regimens in Multiple...
Cancer de prostata11m 38s
Treatment Intensification in Metastatic Castration Sensitive Prostate Cancer
PEACE-1 clinical trial demonstrated that combining ADT and docetaxel with abiraterone acetate plus prednisone (AAP) improves both overall survival (OS) and radiographic progression-free-survival (rPFS) in men with de novo mCSPC.
treatment intensification
mhspc
triplet therapy
peace-1 clinical trial
1
Treatment Intensification in Metastatic Castration...
Myelodysplastic Syndromes14m 13s
ASH 2022 Update on Myelodysplastic Syndromes
ASH 2022 - Update on Myelodysplastic Syndromes
eln classification
low risk mds
low dose lenalidomide
venetoclax
viale -a
tags: azacitidine
1
ASH 2022 Update on Myelodysplastic Syndromes
Oncospecials14m 58s
Is TKI Monotherapy still relevant for advanced Renal Cell carcinoma
ICIs in combination with VEGF-targeted treatments have become standard of care in 1st line advanced RCC ,however there are certain group of patients wherein treatment with single agent TKI can still be considered optimal
1st line rcc
single agent tki
1
Is TKI Monotherapy still relevant for advanced...
Acute Myeloid Leukaemia12m 22s
EHA 2022 Updates : AML
EHA Updates AML : QuANTUM phase 3 study showed significant overall survival in adults having FLT3-ITD+ acute myeloid leukaemia with addition of quizartinib to standard induction and consolidation therapy alone.
aml
decitabine
g-csf
hypomethylating agents
1
EHA 2022 Updates : AML
Cancer de prostata4m 19s
Integrating PARP inhibitors in the treatment of Prostate Cancer
Wherever possible all patients with prostate cancer should undergo both germinal and somatic BRCA mutation testing as they represent predictive biomarkers of greater sensitivity to treatment with PARP inhibitors.
profound clinical trial
parp inhibitors
brca mutation
1
Integrating PARP inhibitors in the treatment of...
Myelodysplastic Syndromes8m 45s
Current Challenges in MDS Diagnosis and Consequences
Bone marrow examination-based diagnosis of MDS with either biopsy or aspirate remains standard of care but is associated with pain, bleeding, difficulty to use the same in elderly patients and hIgh interobserver variability.
non invasive mds diagnosis
web based mds diagnosis tools
1
Current Challenges in MDS Diagnosis and Consequences
Myelodysplastic Syndromes5m 42s
Integrating Molecular Prognositic Systems in Management of MDS
Integrating molecular prognostic systems into MDS clinical practice enhances risk stratification by combining genetic data with traditional scoring systems.
molecular prognostic systems
ipss-m
prediction of disease progression
1
Integrating Molecular Prognositic Systems in...
Oncospecials4m 33s
Case of Advanced Renal Cell Carcinoma patient with Rheumatoid Arthritis treated with single agent TKI
Learn about successful treatment of 72 year old Renal Cell Carcinoma Patient also suffering from Rheumatoid Arthritis treated with single agent TKI
renal cell carcinoma
rheumatoid arthritis
single agent tki
1
Case of Advanced Renal Cell Carcinoma patient with...
Cáncer de mama8m 50s
Immunotherapy of Early Breast Cancer
I-SPY2 clinical trial laid the foundation for Immunotherapy in Early Breast Cancer with Pembrolizumab added to Neoadjuvant Chemotherapy.
keynote -522
immunotherapy
early breast cancer
1
Immunotherapy of Early Breast Cancer
Seminarios web anteriores
Seminarios web anteriores
Webinar Cards Listing
Artículos
Artículos
Medbytes Cards Listing
Iniciar sesión
Por favor inicie sesión para acceder a todo el contenido de MedEnrich
¿Es nuevo/a en MedEnrich? Regístrese ahora